Literature DB >> 21599713

Ethanol impairs differentiation of human adipocyte stromal cells in culture.

David W Crabb1, Yan Zeng, Suthat Liangpunsakul, Rosemarie Jones, Robert Considine.   

Abstract

BACKGROUND: Bioinformatic resources suggest that adipose tissue expresses mRNAs for alcohol dehydrogenases (ADHs) and ALDH2, and epidemiological studies indicate that heavy alcohol use reduces adipose tissue mass. We therefore characterized the expression of alcohol metabolizing enzymes in human, rat and mouse adipose tissue, preadipocytes, and adipocytes, the ability of adipocytes to metabolize ethanol, and the effects of ethanol on differentiation of human adipose stromal cells (hASCs).
METHODS: Adipose tissue, preadipocytes, and adipocytes were collected from rodents or from humans undergoing bariatric surgery. hASCs were differentiated in vitro using standard methods. Gene expression and cellular differentiation were analyzed by Western blotting, RT-PCR, and microscopy.
RESULTS: Class I ADH was expressed in human > mouse > rat adipose tissue, whereas ALDH2 was high in all samples. ADH, catalase, and ALDH2 were induced during differentiation of hASCs. The presence of 50 mM ethanol markedly reduced the differentiation of hASCs; this effect was associated with inhibition of expression of transcription factors required for differentiation, but did not depend on the ability of the cells to metabolize ethanol.
CONCLUSIONS: Human adipose tissue expresses alcohol oxidizing enzymes. The presence of ethanol at physiologically relevant concentrations inhibits differentiation of hASCs. Ethanol could alter adipose tissue biology, inducing a form of acquired lipodystrophy, which is consistent with epidemiological studies. 2011 by the Research Society on Alcoholism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21599713     DOI: 10.1111/j.1530-0277.2011.01504.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  9 in total

1.  ADH1B∗2 Is Associated With Reduced Severity of Nonalcoholic Fatty Liver Disease in Adults, Independent of Alcohol Consumption.

Authors:  Eduardo Vilar-Gomez; Silvia Sookoian; Carlos Jose Pirola; Tiebing Liang; Samer Gawrieh; Oscar Cummings; Wanqing Liu; Naga P Chalasani
Journal:  Gastroenterology       Date:  2020-05-23       Impact factor: 22.682

2.  Increasing serum pre-adipocyte factor-1 (Pref-1) correlates with decreased body fat, increased free fatty acids, and level of recent alcohol consumption in excessive alcohol drinkers.

Authors:  Suthat Liangpunsakul; Rachel Bennett; Chi Westerhold; Ruth A Ross; David W Crabb; Xianyin Lai; Frank A Witzmann
Journal:  Alcohol       Date:  2014-09-28       Impact factor: 2.405

3.  Alcohol consumption promotes diethylnitrosamine-induced hepatocarcinogenesis in male mice through activation of the Wnt/β-catenin signaling pathway.

Authors:  Kelly E Mercer; Leah Hennings; Neha Sharma; Keith Lai; Mario A Cleves; Rebecca A Wynne; Thomas M Badger; Martin J J Ronis
Journal:  Cancer Prev Res (Phila)       Date:  2014-04-28

4.  Alcohol-induced epigenetic alterations to developmentally crucial genes regulating neural stemness and differentiation.

Authors:  Kylee J Veazey; Mindy N Carnahan; Daria Muller; Rajesh C Miranda; Michael C Golding
Journal:  Alcohol Clin Exp Res       Date:  2013-03-12       Impact factor: 3.455

Review 5.  Alcohol, adipose tissue and liver disease: mechanistic links and clinical considerations.

Authors:  Richard Parker; Seung-Jin Kim; Bin Gao
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-09-20       Impact factor: 46.802

6.  Transcriptomic identification of ADH1B as a novel candidate gene for obesity and insulin resistance in human adipose tissue in Mexican Americans from the Veterans Administration Genetic Epidemiology Study (VAGES).

Authors:  Deidre A Winnier; Marcel Fourcaudot; Luke Norton; Muhammad A Abdul-Ghani; Shirley L Hu; Vidya S Farook; Dawn K Coletta; Satish Kumar; Sobha Puppala; Geetha Chittoor; Thomas D Dyer; Rector Arya; Melanie Carless; Donna M Lehman; Joanne E Curran; Douglas T Cromack; Devjit Tripathy; John Blangero; Ravindranath Duggirala; Harald H H Göring; Ralph A DeFronzo; Christopher P Jenkinson
Journal:  PLoS One       Date:  2015-04-01       Impact factor: 3.240

Review 7.  Immunological mechanisms and therapeutic targets of fatty liver diseases.

Authors:  Hua Wang; Wajahat Mehal; Laura E Nagy; Yaron Rotman
Journal:  Cell Mol Immunol       Date:  2020-12-02       Impact factor: 11.530

8.  Influence of fat/carbohydrate ratio on progression of fatty liver disease and on development of osteopenia in male rats fed alcohol via total enteral nutrition (TEN).

Authors:  Martin J J Ronis; Kelly Mercer; Larry J Suva; Jamie Vantrease; Matthew Ferguson; William R Hogue; Neha Sharma; Mario A Cleves; Michael L Blackburn; Thomas M Badger
Journal:  Alcohol       Date:  2014-02-01       Impact factor: 2.405

9.  Vitamin D supplementation protects against bone loss associated with chronic alcohol administration in female mice.

Authors:  Kelly E Mercer; Rebecca A Wynne; Oxana P Lazarenko; Charles K Lumpkin; William R Hogue; Larry J Suva; Jin-Ran Chen; Andrew Z Mason; Thomas M Badger; Martin J J Ronis
Journal:  J Pharmacol Exp Ther       Date:  2012-08-14       Impact factor: 4.030

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.